Login
June 9, 2021 9:00 am Virtual
The role in biotech of special purpose acquisition companies (SPAC) has moved from a rarefied interest to a core option for reaching public markets, attracting investor and regulator attention. Learn through live Q&A with a panel of SPAC deal experts how this popular, volatile tool for raising capital works in practice and will evolve next.
All registrants to this free webinar will receive a copy of the recording, whether you attend or not. This is a pre-event to the BIO Digital International Conference.
Register/Info